drugset / Trial / NCT05797792

CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).

NCT05797792

Phase 3 Active not recruiting 440 enrolled Hospital Clinic of Barcelona
RandomizedParallel-groupSingle-blindTreatment

Summary

Multi-center, randomized, parallel-group, superiority study to compare the efficacy of adjunct intra-arterial rt-PA versus not adjunct intra-arterial rt-PA in the improvement of the efficacy of mechanical thrombectomy in patients with large vessel occlusion acute ischemic stroke.

Timeline

Start
2023-11-18
Primary completion
2025-08-26
Completion
2025-11-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic 0.225 mg/kg Other

Indications